Anna M Georgiopoulos
Overview
Explore the profile of Anna M Georgiopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrigan M, Georgiopoulos A, Quittner A, Smith B, Douglas T
BMJ Open Respir Res
. 2025 Feb;
12(1).
PMID: 39929550
Cystic fibrosis (CF) treatment has revolutionised care over the past three decades with major advances in survival. Despite these advances, CF continues to create psychological and social challenges for people...
2.
Dobra R, Carroll S, Davies J, Dowdall F, Duff A, Elderton A, et al.
Paediatr Respir Rev
. 2024 Sep;
PMID: 39261143
Cystic fibrosis (CF) is traditionally associated with considerable and progressive multisystem pathology, onerous treatment burden, complex psychosocial challenges, and reduced life-expectancy [1-9].This decade has seen transformative change in management for...
3.
Kazmerski T, Stransky O, Lee M, Prangley K, Jain R, Georgiopoulos A, et al.
BMJ Open Respir Res
. 2024 Aug;
11(1).
PMID: 39209351
Introduction: People with cystic fibrosis (CF) are living longer and healthier lives with a growing number considering and pursuing parenthood. The decision of whether to become a parent is complex...
4.
Van Citters A, Aliaj E, Alvarez J, Brown C, Cary J, Cravens R, et al.
J Cyst Fibros
. 2024 Jul;
PMID: 39060182
Background: People with cystic fibrosis (PwCF) have experienced substantial improvements in health following use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies. However, less is known about how modulator...
5.
Georgiopoulos A, DiFiglia S, Seng E, Portenoy R, Chaudhary N, Wei R, et al.
Pediatr Pulmonol
. 2024 Jun;
59(11):2857-2866.
PMID: 38934771
Background: A primary palliative care model for cystic fibrosis (CF) recommends using the Integrated Palliative Care Outcome Scale (IPOS) for screening. Validation of the IPOS is needed. Methods: This secondary...
6.
Kazmerski T, Moy C, Aliaj E, Hudson J, Wright B, Poranski M, et al.
J Cyst Fibros
. 2024 Mar;
23(4):639-646.
PMID: 38485603
Background: To address sexual and reproductive health (SRH) concerns among people with cystic fibrosis(PwCF), the CF Foundation created the Sexual Health, Reproduction, and Gender Research (SHARING) Working Group. This report...
7.
Southern K, Addy C, Bell S, Bevan A, Borawska U, Brown C, et al.
J Cyst Fibros
. 2023 Dec;
23(1):12-28.
PMID: 38129255
This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing...
8.
DiFiglia S, Georgiopoulos A, Portenoy R, Seng E, Berdella M, Friedman D, et al.
J Cyst Fibros
. 2023 Nov;
23(4):804-810.
PMID: 37951787
Background: Little is known about the burden of illness experienced by people with cystic fibrosis (pwCF) since the advent of CF transmembrane conductance regulator (CFTR) modulator therapies. Studies that characterize...
9.
VanElzakker M, Tillman E, Yonker L, Ratai E, Georgiopoulos A
Curr Opin Pulm Med
. 2023 Sep;
29(6):603-609.
PMID: 37655981
Purpose Of Review: This review highlights the problem of neuropsychiatric adverse effects (AEs) associated with elexacaftor/tezacaftor/ivacaftor (ETI), current suboptimal mitigation approaches, a novel testable mechanistic hypothesis, and potential solutions requiring...
10.
DiFiglia S, Dhingra L, Georgiopoulos A, Papia K, Sullivan E, Plachta A, et al.
Life (Basel)
. 2023 Aug;
13(8).
PMID: 37629478
Among people with cystic fibrosis (CF), illness burden is multifaceted, and symptoms may fluctuate in intensity across a lifespan. Caregivers of people with CF may also experience distressing symptoms. Recent...